Travel Nursing Won’t Solve the Staffing Shortage, But Reimagining Staffing Models Might
Shift flexibility is critical to nurse satisfaction.
J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer
Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Momentum is Building to Put Medical Cannabis into Mainstream Healthcare
The Drug Enforcement Agency’s decision to reclassify cannabis to a Schedule III drug could mark the first step in a long process to establish a new normal for medical cannabis care.
What’s Keeping Healthcare CIOs Up at Night: How Health Systems Automate Routine Phone Calls to Improve Workforce Effectiveness and Reduce Agent Burnout
With hospitals struggling to retain staff and value-based care shrinking healthcare revenues, health systems must look to technology resources to become more efficient, without losing sight of patient care or staff support.
Four Innovative Canadian Medtech Startups to Watch at MedCity INVEST
The group of four healthcare startups spans women's health, orthopedics, remote patient monitoring for Parkinson's disease, AI, and 3D printing. David Kereiakes, Managing Partner, Windham Venture Partners will moderate the session.
Abbott Earns FDA Approval For Dissolving Stent That Unclogs Arteries Below The Knee
Abbott earned FDA approval for its dissolving stent designed to unclog arteries below the knee. This marks the first time the FDA has approved a stent or drug-coated balloon to help arteries stay open below the knee.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency
The FDA approved X4 Pharmaceuticals drug Xolremdi for treating WHIM syndrome. The molecule, which addresses the underlying cause of this rare immunodeficiency, was licensed from Sanofi’s Genzyme subsidiary.
Pivot Podcast: A Conversation with Capital Rx CEO A.J. Loiacono
Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of pharmacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx.
Navigating Healthcare’s New Era of Algorithmic Transparency
What EHR/EMR vendors need to know to comply with ONC’s HTI-1 final rule
Ono Pharma’s Plan to Become a Global Player Picks Up a New Piece With $2.4B Deciphera Acquisition
Ono Pharmaceutical’s acquisition of Deciphera Pharmaceuticals adds to a cancer drug pipeline that already spans multiple modalities. Deciphera develops drugs that target the on-off switch of enzymes that drive cancer cell growth.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Inequity in Interoperability: The Haves and Have-Nots & How QHINs Can Help
Interoperability is moving ahead, but major health systems and hospitals in large population centers must ensure they don’t leave their smaller and more rural counterparts behind.
Provider Feedback Loop: The Missing Link in AI Development, Use and Adoption
With the right solutions, providers can spend more time with the patient, building the relationship, earning their trust, and focusing on the forward-looking health journey.
An Oveview of the Nation’s Largest SEED Fund
Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding comes in tranches, from $300,000 - $4 million, based upon the stage of development and likelihood of the end product “moving the needle” in healthcare.
Experts Aren’t Surprised About Optum Closing Its Virtual Care Business
Optum is shutting down its virtual care unit after a three-year run. Industry experts agree that the closure reflects broader trends in the telehealth market, in which saturation and differentiation challenges are leading some providers to struggle.
Demystifying Coding Compliance: 3 Key Strategies for Navigating the Regulatory Waters of RCM
Organizations must take a proactive approach by implementing a comprehensive education program, internal audits, and automation technology.